The FDA OKs pill schizophrenia and bipolar disorder treatment with Bysanti, a new atypical antipsychotic approved for adults.

Antipsychotic medicines are a key part of the pharmacological treatment of schizophrenia. Although they provide therapeutic ...

"If it wasn’t so harmful to people with real mental health challenges searching for real solutions, it would be hilarious." ...

Researchers used genomic structural equation modeling to separate schizophrenia-specific and shared bipolar genetic risks. Schizophrenia-unique variants were linked to lower IQ, while shared variants ...

Researchers review the future of schizophrenia treatment, highlighting TAAR1 agonists, NMDA enhancers, and the gut-brain axis ...

Daybue was turned down for Rett syndrome, and Iloperidone for schizophrenia and bipolar I, with safety and benefit-risk concerns cited in both cases.

Milsaperidone is an active metabolite of iloperidone ...

A new study by researchers at King's College London has split schizophrenia risk into two genetically distinct pathways. One ...

Other cells, such as glial cells, support the function of neurons. Neuroscience has often painted glial cells as the glue that holds neurons together, but glial cells can also be helpful in promoting ...

For decades, schizophrenia and bipolar disorder (BD) were treated as distinct and unrelated psychiatric disorders. Schizophrenia is a psychiatric disorder characterized by altered thinking and ...

Each year, the last week of February is recognized as Eating Disorder Awareness Week. In the days leading up to it, my inbox ...

Babies born during Covid could be at increased risk of schizophrenia when they reach adulthood, Britain’s top psychiatrist ...